Pharmacy Board Insists Generics Are Undersold

Law360, New York (December 18, 2006, 12:00 AM EST) -- An Oklahoma pharmacy board has asked Wal-Mart Stores Inc. and Target Corp. to review their $4 generic drug program, concerned that the retail giants’ rock-bottom prices for certain medications may violate the state’s Unfair Sales Act.

Prompted by a group of upset pharmacists, the Oklahoma State Board of Pharmacy has asked Wal-Mart and Target to make sure that they can sell the generic drugs for that price in light of the state’s competition laws.

“We are not asking them to stop the $4 program,” says Dr....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.